New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Oncology January 29,2024
No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Oncology January 29,2024
Exercise could reduce frailty in the most common form of leukemia

Exercise could reduce frailty in the most common form of leukemia

by University of SurreyCredit: Pixabay/CC0 Public DomainIncreased levels of exercise could help reduce frailty in patients with the most common form of leukemia, chronic lymphocytic (CLL), accord
Oncology January 29,2024
Exercise could reduce frailty in the most common form of leukemia

Exercise could reduce frailty in the most common form of leukemia

by University of SurreyCredit: Pixabay/CC0 Public DomainIncreased levels of exercise could help reduce frailty in patients with the most common form of leukemia, chronic lymphocytic (CLL), accord
Oncology January 29,2024
Screening age needs to be lowered to combat colorectal cancer 'epidemic,' say researchers

Screening age needs to be lowered to combat colorectal cancer 'epidemic,' say researchers

by University of OtagoCredit: Pixabay/CC0 Public DomainNew Zealand needs to lower the screening age for colorectal cancer if it wants to reverse the dramatic increase of people aged under 50 bein
Oncology January 29,2024
Screening age needs to be lowered to combat colorectal cancer 'epidemic,' say researchers

Screening age needs to be lowered to combat colorectal cancer 'epidemic,' say researchers

by University of OtagoCredit: Pixabay/CC0 Public DomainNew Zealand needs to lower the screening age for colorectal cancer if it wants to reverse the dramatic increase of people aged under 50 bein
Oncology January 29,2024
Researchers analyze factors contributing to high levels of esophageal cancer in Tanzania

Researchers analyze factors contributing to high levels of esophageal cancer in Tanzania

byThe City University of New YorkAssociations between the number of hospitals and esophageal cancer incidence with or without Dar es Salam hospital. Credit:Journal of Cancer Epidemiology&n
Oncology January 29,2024
Researchers analyze factors contributing to high levels of esophageal cancer in Tanzania

Researchers analyze factors contributing to high levels of esophageal cancer in Tanzania

byThe City University of New YorkAssociations between the number of hospitals and esophageal cancer incidence with or without Dar es Salam hospital. Credit:Journal of Cancer Epidemiology&n
Oncology January 29,2024
A new targeted treatment shows promise for select patients with stomach cancer

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha
Oncology January 29,2024
A new targeted treatment shows promise for select patients with stomach cancer

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha
Oncology January 29,2024
Research team creates more effective lymphatic cancer therapy

Research team creates more effective lymphatic cancer therapy

byTohoku UniversityThe ex vivo bioluminescence intensity of the metastatic LN was lowest in the Single M-TBI + LDDS group, followed by the Single M-TBI group and the LDDS group, and all these gr
Oncology January 29,2024
Research team creates more effective lymphatic cancer therapy

Research team creates more effective lymphatic cancer therapy

byTohoku UniversityThe ex vivo bioluminescence intensity of the metastatic LN was lowest in the Single M-TBI + LDDS group, followed by the Single M-TBI group and the LDDS group, and all these gr
Oncology January 29,2024
New tools to manage rare eye cancer

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e
Oncology January 29,2024
New tools to manage rare eye cancer

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e
Oncology January 29,2024
Research finds unexpected link between chromosomal instability and epigenetic alterations

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h
Oncology January 29,2024
Research finds unexpected link between chromosomal instability and epigenetic alterations

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h
Oncology January 29,2024
Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind
Oncology January 29,2024
Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind
Oncology January 29,2024
In situ, invasive melanoma diagnoses decreased in 2020

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from
Oncology January 29,2024
In situ, invasive melanoma diagnoses decreased in 2020

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from
Oncology January 29,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com